Co-Authors
This is a "connection" page, showing publications co-authored by Katia Falasca and Francesco Cipollone.
Connection Strength
0.562
-
Duration of COVID-19: Data from an Italian Cohort and Potential Role for Steroids. Microorganisms. 2020 Aug 31; 8(9).
Score: 0.225
-
Canakinumab in a subgroup of patients with COVID-19. Lancet Rheumatol. 2020 Aug; 2(8):e457-ee458.
Score: 0.221
-
Efficacy of canakinumab in mild or severe COVID-19 pneumonia. Immun Inflamm Dis. 2021 06; 9(2):399-405.
Score: 0.116